A Simple Tea-Bowl Ceremony
This is an excerpt from the film MOMENT by MOMENT, the story of a determined woman #39;s physical and psychological recovery from a severe spinal cord injury following a dramatic automobile rollover. Watch the entire film here: concentric.orgFrom:TheConcentricMediaViews:0 0ratingsTime:01:13More inNonprofits Activism

Continued here:
A Simple Tea-Bowl Ceremony - Video

Recommendation and review posted by sam

Warm Water Therapy: A Primary Tool For SCI and Many Other Physical Challenges
This is an excerpt from the film MOMENT by MOMENT, the story of a determined woman #39;s physical and psychological recovery from a severe spinal cord injury following a dramatic automobile rollover. Watch the entire film here: concentric.orgFrom:TheConcentricMediaViews:0 0ratingsTime:02:29More inNonprofits Activism

Read the rest here:
Warm Water Therapy: A Primary Tool For SCI and Many Other Physical Challenges - Video

Recommendation and review posted by sam

Horses and Equine Therapy -- Feeling Ambulation in Your Body
This is an excerpt from the film MOMENT by MOMENT, the story of a determined woman #39;s physical and psychological recovery from a severe spinal cord injury following a dramatic automobile rollover. Watch the entire film here: concentric.orgFrom:TheConcentricMediaViews:0 0ratingsTime:01:16More inNonprofits Activism

Continue reading here:
Horses and Equine Therapy -- Feeling Ambulation in Your Body - Video

Recommendation and review posted by sam

How I Went Far Beyond What Others Said Were Possible. A Look At Healing Modalities and Possibilities
This is an excerpt from the film MOMENT by MOMENT, the story of a determined woman #39;s physical and psychological recovery from a severe spinal cord injury following a dramatic automobile rollover. Watch the entire film here: concentric.orgFrom:TheConcentricMediaViews:0 0ratingsTime:11:56More inNonprofits Activism

Follow this link:
How I Went Far Beyond What Others Said Were Possible. A Look At Healing Modalities and Possibilities - Video

Recommendation and review posted by sam

Caregiving? It #39;s Complicated
This is an excerpt from the film MOMENT by MOMENT, the story of a determined woman #39;s physical and psychological recovery from a severe spinal cord injury following a dramatic automobile rollover. Watch the entire film here: concentric.orgFrom:TheConcentricMediaViews:0 0ratingsTime:06:14More inNonprofits Activism

See the rest here:
Caregiving? It's Complicated - Video

Recommendation and review posted by sam

Breath and Breathing: A Conscious Tool For Well-Being
This is an excerpt from the film MOMENT by MOMENT, the story of a determined woman #39;s physical and psychological recovery from a severe spinal cord injury following a dramatic automobile rollover. Watch the entire film here: concentric.orgFrom:TheConcentricMediaViews:0 0ratingsTime:00:39More inNonprofits Activism

See the rest here:
Breath and Breathing: A Conscious Tool For Well-Being - Video

Recommendation and review posted by sam

Attitude: A Tool for Well-Being
This is an excerpt from the film MOMENT by MOMENT, the story of a determined woman #39;s physical and psychological recovery from a severe spinal cord injury following a dramatic automobile rollover. Watch the entire film here: concentric.orgFrom:TheConcentricMediaViews:0 0ratingsTime:07:12More inNonprofits Activism

Go here to see the original:
Attitude: A Tool for Well-Being - Video

Recommendation and review posted by sam

Robot Bionic Suit Helps Paralyzed Patients Walk Again
Robot Bionic Suit Helps Paralyzed Patients Walk Again A new bionic suit is helping paralyzed patients walk again. Spinal cord injury patient Aaron Bloom has been training with the device for three months. It was first designed to help soldiers carry heavy loads, but is not helping patients balance. Bloom said, "It #39;s great to be upright and walking." The $150000 suit and its use in therapy are not covered by insurance, but rehab specialists say the device can help patients in many ways, including keeping their bones strong.From:hourlyupdatesViews:0 0ratingsTime:02:03More inScience Technology

Go here to read the rest:
Robot Bionic Suit Helps Paralyzed Patients Walk Again - Video

Recommendation and review posted by sam

Back to the Future Academic Conference: Fiorenzo Omenetto and David Kaplan
Watch Dr. David Kaplan and Fiorenzo Omenetto #39;s "The New Silk: A Thread of Discovery" as it was given at Tufts University #39;s Back to the Future event on Tuesday, November 27, 2012 at the Harmonie Club in NYC. Dr. David Kaplan, the Stern Family Professor of Engineering, is a professor and chair of the Department of Biomedical Engineering and holds faculty appointments in the Department of Chemical and Biological Engineering, Department of Chemistry, the Tufts University School of Medicine, and the Tufts University School of Dental Medicine. He has pioneered the study of silk-based biomaterials in regenerative medicine. Fiorenzo Omenetto, Ph.D., the Frank C. Doble Professor in Engineering, is a professor in the Departments of Biomedical Engineering and Physics, and leads the laboratory for Ultrafast Nonlinear Optics and Biophotonics. He has pioneered, with David Kaplan, the use of silk as a material platform for photonics, optoelectronics, and high-technology applications.From:TuftsAlumniViews:4 0ratingsTime:20:28More inEducation

Go here to read the rest:
Back to the Future Academic Conference: Fiorenzo Omenetto and David Kaplan - Video

Recommendation and review posted by sam

Myelin Repair - The People #39;s Hot Topic with Prof. Siddharthan Chandran
Siddarthan Chandran, professor, neurologist and general cricket fanatic answers your questions on Myelin Repair. Siddarthan is the director of the Anne Rowling Clinic for regenerative medicine at the University of Edinburgh - he took some time to meet with Shift.ms and talk to us about some of the work he and his collaborators are doing around myelin repair. Apologies about some of the filming - the camera was on the wrong setting!From:shiftdotmsViews:17 1ratingsTime:11:42More inNonprofits Activism

Continue reading here:
Myelin Repair - The People's Hot Topic with Prof. Siddharthan Chandran - Video

Recommendation and review posted by sam

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/gvftjr/global) has announced the addition of the "Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 - 2017)" report to their offering.

Transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends. Global research and development Network, Innovation and Spin offs have been discussed. The report tracks regional adoption and development trends, providing strategic recommendation to stay active and compete in the market space. An impact analysis of major drivers and restraints influencing the growth of the market is mapped for five year period.

Key Driver:

Advances in cell research and therapeutic delivery

Cell research is a major driving factor for transfection market, as more than 60% of the users are of academic institutions and researchers. Research in gene transfer is being performed in in vivo conditions for different therapeutic applications; there is a growing demand for new transfection technologies to address unmet needs for therapeutic delivery which is driving the transfection market.

Key Restraint:

Home brew Reagents restricts sale of commercial kits

Home brew reagents are still the preferred choice of reagents for transfection by researchers all over the world. Most of the researchers prepare their own reagents from their laboratory to conduct their research. This is true for most of the reagent based transfection reactions. This allows them to reduce cost involved in purchasing commercial kits.

Key Challenge:

Original post:
Research and Markets: Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies ...

Recommendation and review posted by Bethany Smith

Christmas Party 2012 - Gangnam Girls
II- Genetics Christmas Party Dec. 20, 2012 ^^ Song: Remix~ By: Remix! Dancers: April, Rox, Mai.o2, Ganda (Grace xD), Alyssa Camera: Me :DFrom:Rui Musume KageneViews:0 0ratingsTime:03:53More inEntertainment

See the original post:
Christmas Party 2012 - Gangnam Girls - Video

Recommendation and review posted by Bethany Smith

Plan My Baby. Baby gender predictor, Can you really choose your baby #39;s gender? Testimonial.
yupurl.com - Plan My Baby. Baby gender predictor, Can you really choose your baby #39;s gender? Testimonial. What you hear in the short video testimonial above is true story the persons who follow the this program. The owner of "Plan My Baby" program claim the method they use is 94% accurate base on some people already follow they program. Baby gender predictor is actually a controversial topic, especially in relation to genetic therapy as well as ethics of picking the sex of your respective child. While there certainly have already been advances in the field of genetics, you can get some natural and completely ethical issues that it can be done will increase the chance of deciding on a gender on your child. While no strategy is 100% accurate, for anyone who is determined to possess a boy or perhaps a girl, usually there are some issues that can be carried out to significantly grow your chances of conceiving the gender which you decide on. Remember, it is important will be to use a healthy baby, regardless of their gender. But if you need to do would like to try to decide on the gender of one #39;s child or baby gender predictor it will be easy. Some tips about what consider know. Variations in Sperm. The sperm that carry the Y chromosome are classified as the "boy" sperms, as you move the ones that carry the X chromosome are definitely the "girl" sperms. The Y sperm are faster, smaller, more agile however tend not to last as long as the "girl" sperm. The X sperm are bigger and ...From:planmybaby80Views:0 1ratingsTime:02:50More inNews Politics

Read the original post:
Plan My Baby. Baby gender predictor, Can you really choose your baby's gender? Testimonial. - Video

Recommendation and review posted by Bethany Smith

"Bucca" German Shepherd with strong genetics for bite work! http://www.K9-1.com
We recently were giving the opportunity to use Bucca as a stud for our most recent German Shepherd litter with our very strong and stable female Nora. This is a demo of the dog #39;s BITE and not his training. All pups will be placed with either experienced working handlers or with training and handler lessons at our facility. Dog training, personal protection dog sales, and courses for the dog training student available at our facility. Contact us at http://www.k9-1.comFrom:k91dogtrainingViews:103 4ratingsTime:02:00More inPets Animals

Originally posted here:
"Bucca" German Shepherd with strong genetics for bite work! http://www.K9-1.com - Video

Recommendation and review posted by Bethany Smith

Genetics in Edinburgh: the early days
A journey through the birth of genetics at Edinburgh, via our Towards Dolly projectFrom:euarchivesViews:0 0ratingsTime:02:31More inNews Politics

See more here:
Genetics in Edinburgh: the early days - Video

Recommendation and review posted by Bethany Smith

SEATTLE, WA--(Marketwire - Dec 20, 2012) - Atossa Genetics, Inc. ( NASDAQ : ATOS ) today announced financial results for the third quarter of 2012, ended September 30, 2012.

"During the third quarter of 2012, we successfully completed our initial public offering of 800,000 shares at $5.00 per share, the midpoint of our price range. The proceeds from the IPO will enable us to accelerate the national roll-out of our first FDA-cleared and marketed product, the ForeCYTE Breast Health Test for breast cancer risk assessment," stated Steven C. Quay, M.D., Ph.D., Chairman, President and CEO. "Our IPO was the only biotech IPO priced in the month of November and was priced in the immediate aftermath of Hurricane Sandy. I believe this is a testament to the strength of our business model and the significant revenue and earnings potential of Atossa Genetics over the next several years as we pursue the further commercialization of the ForeCYTE and ArgusCYTE tests with the 5,000-strong launch team through our marketing partner, Diagnostics Testing Group, LLC, the commercialization of two new tests in 2013, and the advancement of our intraductal therapeutics program to safely and effectively treat pre-cancerous breast lesions."

Third Quarter 2012 Results

Total revenues for the third quarter of 2012 were $105,576, comprising $104,011 in diagnostic testing services and $1,565 in product sales, versus no revenues for the third quarter of 2011. The ForeCYTE and ArgusCYTE tests were launched through a field experience trial beginning in December 2011 and are expected to be rolled out nationally starting in early 2013.

Gross margin for the third quarter was 86 percent on gross profit of $90,499.

Operating expenses are comprised of selling, general and administrative (SG&A) expenses and research and development. For the third quarter of 2012, total operating expenses were $1.23 million versus $1.27 million for the third quarter of 2011.

Net loss for the third quarter ended September 30, 2012, was $1.14 million, or ($0.10) per share, versus a net loss of $1.27 million, or ($0.11) per share, for the year-ago quarter.

As of September 30, 2012, the Company had cash and cash equivalents of $418,570 versus $1.91 million at the end of December 2011. The company completed its IPO in November 2012, raising $4.0 million in gross proceeds prior to expenses and net proceeds of approximately $3.5 million.

Corporate Highlights

About Atossa Genetics, Inc.

Read the original here:
Atossa Genetics Announces Third Quarter 2012 Financial Results

Recommendation and review posted by Bethany Smith

SEATTLE, WA--(Marketwire - Dec 21, 2012) - Atossa Genetics, Inc. ( NASDAQ : ATOS ), The Breast Health Company, announced today that Christopher S. Destro has joined the Company as Vice President of Sales and Marketing, reporting to Dr. Steven C. Quay, MD, PhD, FCAP, Chairman, CEO and President. Mr. Destro, an industry veteran with over 16 years of successful sales and client management expertise within the clinical sector of diagnostic biotechnology, will be responsible for product marketing, distribution and sales.

"The Company is very fortunate to have Christopher Destro join us as Vice President of Sales and Marketing at this pivotal time," said Dr. Quay. "As we accelerate the national roll-out of our ForeCYTE and ArgusCYTEBreast Health Tests in early 2013, Chris' extensive industry experience and in-depth market and technical expertise will be invaluable in helping us achieve our ambitious growth objectives."

"Atossa Genetics is an exciting and dynamic opportunity and I look forward to working with the team to commercialize the Company's products and services for the benefit of millions of women. Atossa has already demonstrated the ability to make a difference in women's lives," commented Mr. Destro. "Over the past two decades, I have assembled and led teams that have achieved high growth in the diagnostic biotechnology solutions markets. I look forward to contributing to the next phase of Atossa's growth as we expand the commercialization of our innovative products and services in the U.S."

Mr. Destro continued, "One of the things that attracted me to Atossa is its novel and revolutionary approach to diagnosing, treating and preventing Breast Cancer. I believe this uniquely positions us to expand the commercialization of our potentially life-saving and market-changing solutions at a time when the need is greater than ever."

From 2007 to 2011, Mr. Destro, (42), served in increasingly responsible positions including Vice President of Sales, North America, for three divisions of Magellan Biosciences, where he managed sales of automated blood culture and automated susceptibility instrumentation for Trek Diagnostics, automated immunochemistry for Dynex and a lead care platform for Point of Care testing. In July 2011, Magellan was acquired by Thermo Fisher Scientific, where Mr. Destro became a commercial leader of the Microbiology Division, working with national contracts, distribution channels, and direct sales in the clinical, pharmaceutical, and industrial markets.Prior to joining Magellan, Mr. Destro served as Americas Sales Director for International Bioproducts from 2000 to 2007, where he managed sales of core food pathogen diagnostic (ELISA) products while leading 17 distributors for the United States, Canada, Mexico and Latin America. Mr. Destro holds a Bachelor of Science degree in Microbiology from Ohio State University.

On December 20, 2012, and as an inducement to cause Mr. Destro to join the Company, he was awarded an option to purchase a total of 200,000 shares of common stock of the Company, par value $0.001 per share, outside the Company's 2010 Stock Option and Incentive Plan. The stock option has an exercise price equal to $4.11 per share, the fair market value on the grant date and vests over a four-year period from his commencement of service. This stock option was granted as an inducement material to Mr. Destro's entering into employment with the Company and is being reported in accordance with NASDAQ Listing Rule 5635(c)(4).

About Atossa Genetics, Inc.

Atossa Genetics, Inc. ( NASDAQ : ATOS ), The Breast Health Company, is based in Seattle, WA, and is focused on preventing breast cancer through the commercialization of patented, FDA-cleared diagnostic medical devices and patented, laboratory developed tests (LDT) that can detect precursors to breast cancer up to eight years before mammography, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.

The National Reference Laboratory for Breast Health (NRLBH), a wholly owned subsidiary of Atossa Genetics, Inc., is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, WA, that provides the patented ForeCYTE Breast Health Test, a risk assessment test for women 18 to 73 years of age akin to the Pap Smear, and the ArgusCYTE Breast Health Test, a blood test for recurrence in breast cancer survivors that provides a "liquid biopsy" for circulating cancer cells and a tailored treatment plan for patients and their caregivers.

For more information about this press release, please click the following link: http://client.irwebkit.com/AtossaGenetics/media to view a video interview with Dr. Quay discussing Atossa Genetics and Christopher Destro's role with the Company. You may also sign up to receive automatic email News Alert updates.

Visit link:
Christopher S. Destro Joins Atossa Genetics as Vice President of Sales and Marketing

Recommendation and review posted by Bethany Smith

Stem cell therapy procedure
This is a live video of stem cell therapy by intra-arterial procedure to a DMD patient. Muscualr Dystrophy Foundation India has been assisting patients in stem cell therapy in India. Please do visit http://www.mdfindia.orgFrom:MusclecampaignViews:2 0ratingsTime:01:39More inNonprofits Activism

Excerpt from:
Stem cell therapy procedure - Video

Recommendation and review posted by simmons

PURTIER PRESENTATION
Please contact Mr.SAMSIUR SAUDJANA @ JAKARTA :+6281699062 Live cell therapy is a very effective stem cell therapy for improving health and even disease treatment other than for beauty and anti-aging.From:SAMSIUR SAUDJANAViews:1 0ratingsTime:09:00More inScience Technology

View post:
PURTIER PRESENTATION - Video

Recommendation and review posted by simmons

Donna Skerrett of Mesoblast on adult stem cell therapies - at Stem Cells USA RM Congress 2012
Donna Skerrett, Chief Medical Officer of Mesoblast, presented a case study on Mesoblast and their adult stem cell therapy at the Stem Cells USA Regenerative Medicine Congress 2012. The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:21:30More inScience Technology

Originally posted here:
Donna Skerrett of Mesoblast on adult stem cell therapies - at Stem Cells USA

Recommendation and review posted by simmons

Animal Stem Cell Therapy
Dr Tim O #39;neill DVM hard at work showing you the amazing results of stem cell and Platlete Rich Plasma treatment.From:Greg SantiniViews:0 0ratingsTime:01:03More inPets Animals

Link:
Animal Stem Cell Therapy - Video

Recommendation and review posted by simmons

Success Rate of Stem Cell Treatments in Mexico
http://www.mexicohealth.com The video shows a pioneering stem cell surgeon discussing the success rate of stem cell treatments in Mexico. He proclaims more than 80% of his patients show a positive response to the initial therapy. Those who respond well keep returning to his clinic in Tijuana since they start seeing marked improvements in their otherwise irredeemable conditions such as, multiple sclerosis, brain damage, or heart disease. This stem cell specialist from Tijuana has cured over 40 patients for critical illnesses. Claim your FREE quote for stem cell treatments in Mexico by clicking the link above. Related Searches: Successes of Adult Stem Cell Treatments Mexico, success rate for stem cell therapy Mexico, stem cell transplant success rates Mexico, success rate of embryonic stem cells Mexico, Effectiveness of stem cell therapy mexico, stem cell transplant success mexico,From:mexicohealthViews:4 0ratingsTime:01:00More inPeople Blogs

Read the original:
Success Rate of Stem Cell Treatments in Mexico - Video

Recommendation and review posted by simmons

Treatment Plan for Stem Cells Transplantation in Mexico - Part 2
The video shows a leading stem cell therapist in Mexico discussing in detail the day wise break-up of a treatment plan for stem cell transplantation in Mexico. This is part 2 of the video. This surgeon is one of the pioneers in stem cell research and has cured over 40 patients for otherwise fatal diseases. Over 80% of the patients respond well to the initial treatment he bestows. Despite his track record, the world is still skeptical of stem cell therapies. Many who #39;ve taken a leap of faith by choosing this doctor, found it sufficiently rewarding. The doctor operates from Tijuana, Mexico and you can order a free quote for stem cell transplantation at his Mexico clinic by clicking the link above. Related Searches: stem cell therapy treatment plan mexico, Patient Treatment Plans stem cell Mexico, adult stem cell treatment mexico, autologous stem cell transplant mexico, allogeneic stem cell transplant mexico,From:mexicohealthViews:3 0ratingsTime:01:50More inPeople Blogs

View post:
Treatment Plan for Stem Cells Transplantation in Mexico - Part 2 - Video

Recommendation and review posted by simmons

Treatment Plan for Foreign Patients - Stem Cells Doctor Mexico
http://www.mexicohealth.com The video shows a top stem cell doctor from Mexico going into the details of treatment plan by breaking it up into day-wise events. The treatment lasts 4-5 days, after which the patients can return to their countries. Tijuana, the doctor #39;s home, is especially appealing to Americans as it offers geographical advantage and low cost stem cell treatments for incurable cases. True that the therapy is far from mainstream, this surgeon #39;s track record of curing over 40 patients is an insight into efficacy of the therapy. He claims more than 80% of the patients respond well to his initial therapy. Get a free quote by stem cells doctor in Mexico by clicking the link above. Related Searches: stem cell therapy treatment plan mexico, Patient Treatment Plans stem cell Mexico, adult stem cell treatment mexico, autologous stem cell transplant mexico, allogeneic stem cell transplant mexico,From:mexicohealthViews:5 0ratingsTime:03:48More inPeople Blogs

Originally posted here:
Treatment Plan for Foreign Patients - Stem Cells Doctor Mexico - Video

Recommendation and review posted by simmons

What Are Stem Cells - Mexico Specialist
http://www.mexicohealth.com The video shows a stem cell specialist from Mexico explaining in layman terms the stems cells and how they #39;re harvested. This specialist operates from Tijuana where he has been dedicated to finding a perfect recipe for different life threatening conditions and he has tasted success. With an astonishingly high initial response of over 80%, the doctor has cured over 40 patients for conditions like multiple sclerosis, brain damage, eye problems and cardiac problems. To get a free quote by Mexico specialist in stem cell therapy, click the link above. Related Searches: What are stem cells stem cell definitionFrom:mexicohealthViews:3 0ratingsTime:01:05More inPeople Blogs

Follow this link:
What Are Stem Cells - Mexico Specialist - Video

Recommendation and review posted by simmons